Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer

Robert C. Doebele; David Spigel; Mustapha Tehfe; Sachdev Thomas; Martin Reck; Sunil Verma; Janice Eakle; Frederique Bustin; Jerome Goldschmidt; Dachuang Cao; Ekaterine Alexandris; Sergey Yurasov; D. Ross Camidge; Philip Bonomi

doi:10.1002/CNCR.29132

Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer

Robert C. Doebele
, David Spigel
, Mustapha Tehfe
, Sachdev Thomas
, Martin Reck
, Sunil Verma
, Janice Eakle
, Frederique Bustin
, Jerome Goldschmidt
, Dachuang Cao
, Ekaterine Alexandris
, Sergey Yurasov
, D. Ross Camidge
, Philip Bonomi

Anschutz Medical Campus
Sarah Cannon Research Institute
Université de Montréal
Oncology Hematology Associates of Central Illinois Peoria Illinois
Department of Thoracic Oncology, Lung Clinic GrosshansdorfGerman Center for Lung ResearchGrosshansdorf Germany
Sunnybrook Odette Cancer Centre Toronto Canada
Florida Cancer Specialists Fort Myers Florida
Citadelle Regional Hospital Center Liege Belgium
Oncology and Hematology Associates of Southwest VA, Incorporated Christianburg Virginia
Eli Lilly and Company
Clovis Oncology, LLC San Francisco California
Rush University Medical Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer
Volume	121
Issue number	6
DOIs	https://doi.org/10.1002/CNCR.29132
State	Published - Mar 15 2015
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1002/CNCR.29132License: Unspecified

Cite this

Doebele, R. C., Spigel, D., Tehfe, M., Thomas, S., Reck, M., Verma, S., Eakle, J., Bustin, F., Goldschmidt, J., Cao, D., Alexandris, E., Yurasov, S., Camidge, D. R., & Bonomi, P. (2015). Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer. Cancer, 121(6). https://doi.org/10.1002/CNCR.29132

Doebele, RC, Spigel, D, Tehfe, M, Thomas, S, Reck, M, Verma, S, Eakle, J, Bustin, F, Goldschmidt, J, Cao, D, Alexandris, E, Yurasov, S, Camidge, DR & Bonomi, P 2015, 'Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer', Cancer, vol. 121, no. 6. https://doi.org/10.1002/CNCR.29132

@article{ea57f07ea33846b0af8fd0d4522ce15b,

title = "Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer",

author = "Doebele, \{Robert C.\} and David Spigel and Mustapha Tehfe and Sachdev Thomas and Martin Reck and Sunil Verma and Janice Eakle and Frederique Bustin and Jerome Goldschmidt and Dachuang Cao and Ekaterine Alexandris and Sergey Yurasov and Camidge, \{D. Ross\} and Philip Bonomi",

year = "2015",

month = mar,

day = "15",

doi = "10.1002/CNCR.29132",

language = "American English",

volume = "121",

journal = "Cancer",

issn = "1097-0142",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer

AU - Doebele, Robert C.

AU - Spigel, David

AU - Tehfe, Mustapha

AU - Thomas, Sachdev

AU - Reck, Martin

AU - Verma, Sunil

AU - Eakle, Janice

AU - Bustin, Frederique

AU - Goldschmidt, Jerome

AU - Cao, Dachuang

AU - Alexandris, Ekaterine

AU - Yurasov, Sergey

AU - Camidge, D. Ross

AU - Bonomi, Philip

PY - 2015/3/15

Y1 - 2015/3/15

UR - https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29132

U2 - 10.1002/CNCR.29132

DO - 10.1002/CNCR.29132

M3 - Article

SN - 1097-0142

VL - 121

JO - Cancer

JF - Cancer

IS - 6

ER -

Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer

Disciplines

Access to Document

Other files and links

Cite this